Skip to main content
Leukemia
Emerging Mutations in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Relapsed on Gilteritinib
Read More
Chronic Myeloid Leukemia
Low-Dose Cytarabine plus Quizartinib versus Low-Dose Cytarabine Monotherapy in Older Patients with Acute Myeloid Leukemia: The LI-1 Trial
Read More
Leukemia
Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia
Read More
Leukemia
CLL1-CD33 Compound CAR (cCAR) T-Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia
Read More
Melanoma
Real-World Analysis Finds That Dabrafenib/Trametinib Combination Is Effective in Patients with BRAF V600-Mutated Melanoma with Brain Metastases
Read More
Melanoma
Effectiveness of Dual Immunotherapy Confirmed for Patients with Metastatic Melanoma and Autoimmune Disease
Read More
Melanoma
Symptoms from Immunotherapy/Targeted Therapy Most Mentioned Topic by Patients with Melanoma on Health-Related Social Media
Read More
Melanoma
Complete Responses Equally Durable with Shorter versus Longer Immunotherapy Courses in Advanced Melanoma
Read More
Melanoma
Combination Ipilimumab/Nivolumab Better Than Single-Agent Anti–PD-1 Regardless of BRAF Status in Advanced Melanoma
Read More
Lung Cancer
Durvalumab in Combination with Chemotherapy as First-Line Treatment for Extensive-Stage SCLC (CASPIAN Data)
Read More
Page 122 of 196
Results 1211 - 1220 of 1954